HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yulin Jin Selected Research

Yulin Jin Research Topics

Disease

8Neoplasms (Cancer)
03/2019 - 10/2014
3Infections
03/2022 - 01/2017
3Sepsis (Septicemia)
03/2022 - 02/2017
3Bacterial Infections (Bacterial Infection)
12/2018 - 01/2017
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2017 - 01/2017
2Hypoxia (Hypoxemia)
03/2019 - 02/2017
1Congenital Hyperinsulinism
01/2022
1Brain Diseases (Brain Disorder)
01/2022
1Nervous System Diseases (Neurological Disorders)
11/2019
1Neurodegenerative Diseases (Neurodegenerative Disease)
11/2019
1Adenocarcinoma of Lung
07/2017
1Disease Resistance
01/2017
1Esophageal Squamous Cell Carcinoma
01/2017
1Type 2 Diabetes Mellitus (MODY)
06/2004
1Proteinuria
06/2004
1Cardiovascular Diseases (Cardiovascular Disease)
06/2004
1Atherosclerosis
06/2004

Drug/Important Bio-Agent (IBA)

3RNA (Ribonucleic Acid)IBA
03/2022 - 09/2017
3Oxygen (Dioxygen)IBA
01/2018 - 01/2017
3MicroRNAs (MicroRNA)IBA
07/2017 - 10/2014
2ApolipoproteinsIBA
01/2017 - 06/2004
1Genetic Markers (Genetic Marker)IBA
03/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1Cell-Free Nucleic AcidsIBA
01/2022
1ChromatinIBA
11/2019
1Proteins (Proteins, Gene)FDA Link
11/2019
1Circular RNAIBA
03/2019
1Mitogen-Activated Protein KinasesIBA
03/2019
1Recombinant DNA (Recombinant DNA Research)IBA
12/2018
1Messenger RNA (mRNA)IBA
07/2017
1Apolipoproteins E (ApoE)IBA
01/2017
118S Ribosomal RNAIBA
01/2017
15S Ribosomal RNAIBA
01/2017
1Apolipoproteins C (ApoC)IBA
01/2017
1Apolipoproteins B (ApoB)IBA
01/2017
1Apolipoproteins AIBA
01/2017
1Complementary DNA (cDNA)IBA
07/2016
1AlbuminsIBA
06/2004
1Triglycerides (Triacylglycerol)IBA
06/2004
1LDL Lipoproteins (beta Lipoproteins)IBA
06/2004
1CreatinineIBA
06/2004
1CholesterolIBA
06/2004
1oxidized low density lipoproteinIBA
06/2004
1LDL glycated lipoproteinsIBA
06/2004

Therapy/Procedure

2Drug Therapy (Chemotherapy)
01/2018 - 01/2018
1Pancreatectomy
01/2022
1Radiotherapy
01/2018
1Transcutaneous Electric Nerve Stimulation (TENS)
02/2017